Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Prevent Blindness Issues Call for Nominations for the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health, and Rising Visionary Award


The Jenny Pomeroy Award for Excellence in Vision and Public Health is presented annually to an individual, group, or organization that has made significant contributions to the advancement of public health related to vision and eye health at the community, state, national, and/or international level. The award was created as a living memorial to Jenny Pomeroy, former CEO of Prevent Blindness Georgia from 1996 until 2013, who served as a leader in advancing public health and policy, and was a champion for vision and eye health issues.

Submission requirements for the Jenny Pomeroy Award for Excellence in Vision and Public Health include:

  • Nomination form
  • A 500-word (or less) description of why the nominee is deserving of this award.
  • A one-page biographical sketch (NIH format), one-page curriculum vitae of the nominee, or one-page background of the group/organization

Applicants for the award may also include any additional material that may be relevant to the nomination.

The recipient of the 2023 Jenny Pomeroy Award for Excellence in Vision and Public Health was Dean A. VanNasdale, Jr., OD, PhD, Associate Professor at The Ohio State University (OSU) College of Optometry.

The Prevent Blindness Rising Visionary Award is presented annually to a student or resident in a health-related field who submits the best overall application and essay addressing the 2024 Focus on Eye Health Summit theme, “Being Seen and Heard.” Applicants must be a current student, intern, or resident located in the United States in optometry, ophthalmology, primary health care, nursing, psychology, or another health-related field.

Submission requirements for the Prevent Blindness Rising Visionary Award include:

  • Application Cover Sheet
  • Essay: 500-word essay identifying an opportunity in which engaging the preferences, cultural background, and social context of patients and/or caregivers in development of vision and eye health research, programs, or policy can lead to more impactful outcomes.
  • Curriculum Vitae and Personal Statement
  • Letters of Recommendation

The 2023 Rising Visionary Award recipient was Christina Ambrosino, Johns Hopkins School of Medicine.

“Both the Jenny Pomeroy Award for Excellence in Vision and Public Health, and the Rising Visionary Award, provide us the opportunity to recognize the tremendous efforts of those dedicated to improving our nation’s vision and eye health,” said Jeff Todd, president and CEO of Prevent Blindness. “We encourage everyone to share our announcement about these awards with their colleagues, program partners, and students, and to submit their nominations or applications today!”

For more information on the Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health and past recipients, please visit https://preventblindness.org/jenny-pomeroy-award-for-excellence-in-vision-and-public-health/. Information on the Prevent Blindness Rising Visionary Award may be found at https://preventblindness.org/rising-visionary-award/. Or contact Nita Sinha, director of Public Health, at [email protected].

About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, X, Instagram, Threads, LinkedIn and YouTube.

Media Contact

Sarah Hecker, Prevent Blindness, 312.363.6035, [email protected], PreventBlindness.org

Twitter

SOURCE Prevent Blindness



Professional Physical Therapy Celebrates 25 Years of Excellence in Patient Care


A success story built on the pillars of commitment to our patients.

MELVILLE, N.Y., Jan. 4, 2024 /PRNewswire-PRWeb/ — Professional Physical Therapy is proud to announce the celebration of its 25th anniversary, marking a quarter-century of providing exceptional care and rehabilitation services to their communities throughout New York, New Jersey, Connecticut, Massachusetts, and New Hampshire. Since the opening of their first clinic in 1999, Professional has been dedicated to improving lives of countless individuals through personalized, cutting-edge physical therapy.

“This 25-year milestone is a testament to the hard work, dedication, and passion of our employees, along with the exceptional care our clinicians provide to their patients every day. This has sustained and fueled our growth over the past 25 years”, said Steve Schneider, CEO of Professional Physical Therapy.

From humble beginnings, Professional has grown into a leading provider of physical and occupational therapy with over 200+ locations, across 5 states and a team of over 600 therapists and over 35,000 referring doctors. In the beginning, services provided focused mainly on physical therapy, including outpatient orthopedics, post-operative and preventative skilled care. Now Professional offers over 20 specialty services including Graston Technique, McKenzie Method, Vestibular Therapy, Pelvic Floor, dry needling, aquatic therapy, Active Release Techniques, mulligan concept, LSVT BIG treatment, TMJ and more.

“Our success story is built upon the pillars of commitment to our patients, innovation in treatment techniques, and unwavering dedication to professional excellence. We have consistently strived to exceed the expectations of our patients, helping them regain mobility, alleviate pain, and improve their overall quality of life”, said George Papadopoulos, Co-Founder/Chief Development Officer.

While expansion and growth are still among the top priorities for its leadership team, Professional remains focused on providing best in class patient care. At Professional, their revolutionary services provide patients with multi-specialty Physical Therapists who can treat any body part and injury with excellence. Professional’s clinical expertise and exceptional patient experience has made them:

  • Industry leader that ranks in the top quartile across all clinicians in the US that use technology to measure impact and success of their therapy.
  • Northeast’s largest physical therapy provider with over 200+ locations.
  • Largest Hand Therapy provider in the Northeast with more than 70 hand therapists on their team.
  • Leader in world class clinical education for superior patient results. Clinical Excellence Program is widely respected as the most comprehensive program for personal, professional and leadership growth.

In recognition of the 25th Anniversary, Professional created a history timeline with many significant milestones. A few highlights include:

  • 1999 – Opens first clinic in Bayside, Queens.
  • 2005 – Opens Professional Athletic Performance Center (PAPC).
  • 2011 – Starts the Clinical Excellence Program.
  • 2016 – Expands services to include Occupational Therapy/Hand Therapy.
  • 2017 – Expands footprint to include clinics in Massachusetts and New Hampshire.
  • 2019 – Introduces Telehealth to our patients.
  • 2024 – Reaches milestone of over 200 locations.

For more information and a list of all Professional Physical Therapy locations and services, please visit http://www.professionalpt.com

About Professional Physical Therapy
Professional Physical Therapy was founded in 1999 and is an industry leader, providing private outpatient physical and hand therapy services throughout the Northeast. Our clinical team is comprised of multi-specialty Physical, Hand and Occupational Therapists who can treat a wide variety of orthopedic injuries and conditions with excellence. Today, Professional has grown to include over 200 facilities in New York, New Jersey, Connecticut, Massachusetts, and New Hampshire.

Media Contact

Professional Physical Therapy, Professional Physical Therapy, 516-321-2400, [email protected], https://www.professionalpt.com/

SOURCE Professional Physical Therapy

Medical Spa Expert ARA Med Spa Joins Exclusive Haute Beauty Network


Originally born and raised in London, she received her medical doctorate from the globally renowned Imperial College London. Since then, Dr. Khan has gained over 15 years of experience as a medical doctor in Los Angeles including extensive training across internal medicine, medical imaging, and minimally invasive interventional treatments. She has expertise in treating varicose veins and spider veins with endovenous laser treatment and sclerotherapy at Cedars Sinai Marina Del Rey Hospital.

Learn more about ARA Med Spa by visiting: https://hauteliving.com/hautebeauty/member/ara-med-spa/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Media Contact

Grace Sarkisian, Haute Beauty by Haute Living, (813)-260-0767, [email protected], https://hauteliving.com/hautebeauty/

SOURCE Haute Beauty by Haute Living

NeuroX1 Inc. and Everlum Bio Inc. have established a co-development partnership focused on accelerating the pre-clinical development of small molecule therapeutics


Rick Barkley, CEO of Everlum Bio Inc., added, “This partnership with NeuroX1 Inc. is a testament to our commitment to advancing neurological therapeutics, particularly in the area of rare pediatric neurological diseases. By leveraging Chiron and our proprietary in vitro platform, we are poised to make significant strides in developing effective treatments for some of the most challenging neurological conditions.”

About NeuroX1 Inc.

NeuroX1 Inc. is a biotechnology company based in Austin, Texas, specializing in AI-enabled drug discovery. Its platform, Chiron, uses physics-based generative chemistry to design novel therapeutics for neurological conditions. NeuroX1’s approach aims to streamline the drug development process, reduce costs, and bring eQective treatments to market faster.

About Everlum Bio Inc.

Everlum Bio Inc., also based in Austin, Texas, is a biotech company focused on personalized medicine and known for its expertise in in vitro platform technologies and translational science. The company specializes in developing and validating innovative therapeutic solutions, with a focus on rare and neglected neurological diseases. Everlum Bio Inc. is dedicated to bridging the gap between discovery and clinical application.

For More Information, Please Contact:

NeuroX1 Inc. Email: [email protected]

Everlum Bio Inc. Email [email protected]

Forward-Looking Statements

This press release contains forward-looking statements regarding the partnership’s future plans and expected outcomes. These statements are based on current expectations and are subject to risks and uncertainties. Actual results may differ materially due to various factors, including but not limited to, technological challenges, regulatory hurdles, and market conditions.

Media Contact

Rick Barkley, Everlum Bio, 1 512-698-8913, [email protected]https://everlum.bio

SOURCE Everlum Bio

Patina and Humana team to deliver convenient, relationship-centered primary care to Medicare Advantage members in the Charlotte region


Patina’s approach to primary care is rooted in deep, trusting relationships with patients. Care is provided through a dedicated team that includes a primary care practitioner (PCP) and a Patina health champion, who assists with everything from appointment scheduling and help with accessing needed resources to care coordination across specialists. Through a blend of virtual and in-home visits when needed, Patina gives patients the time they need to feel seen and heard while providing easy access to quality care and a more convenient experience that addresses their total health and well-being.

“Our mission is to transform healthcare, ensuring it is a personalized and holistic experience,” said Jack Stoddard, CEO of Patina. “Our partnership with Humana allows us to bring a better care experience to even more people in the Charlotte area, offering older adults and their loved ones the high-quality, convenient care they deserve to help them live well and thrive.”

“We’re committed to providing our members with access to high-quality primary care and are thrilled to be adding Patina as an option in our expanding network in the Charlotte area,” said Kathleen Schwarzwalder, Market Vice President, Humana. “Patina’s relationship-based care and ability to reach all of our members, no matter where they live across the region, aligns well with our focus on healthy equity and addressing members’ total health and well-being.”

Patina’s care model leverages the company’s expertise in aging and support for older adults, enabling a proactive approach that anticipates and addresses the issues common to this stage of life. With Patina, patients can expect swift appointment scheduling, often within 24-48 hours, and frequent, secure access to their care team through video, web or mobile app, and phone. When in-person care is needed, Patina’s clinicians visit patients at home, utilizing remote monitoring tools to share important health data with the broader care team. This virtual-first approach greatly expands patient access to quality care, especially for those who live in suburban and rural areas that may lack easily accessible provider offices or clinics.

The expansion with Humana in the Charlotte market marks a significant milestone in Patina’s growth, enabling the company to offer its primary care services to more than 170,000 Medicare Advantage members in the region served by Humana, UnitedHealthcare, Aetna and Cigna. Patina also accepts Original Medicare and Medigap insurance plans, further extending care options for Medicare beneficiaries across the Charlotte area. For more information about Patina, visit https://patinahealth.com.

About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

About Patina
PatinaTM is reinventing primary care from the ground up to provide the healthcare and aging experience that older adults and their loved ones deserve. Each person we serve gets a dedicated care team built around them composed of primary care clinicians, a health champion and behavioral health and other specialists – all enabled by purpose-built technology and analytics. As a value-based primary care model, we are focused on delivering a high-quality, high-value experience to the people we serve. The company is backed by leading investors Andreessen Horowitz (a16z), Google Ventures (GV), F-Prime, Viking Global Investors and Rock Springs Capital.

Patina is a collaboration between Patina Medical Groups, virtual and home-based medical practices that provide clinical services to Medicare beneficiaries as well as members of participating Medicare Advantage plans, and Patina Health, Inc., which provides administrative and management services to support Patina Medical Groups’ business operations and non-clinical quality assurance, as well as advanced information technology and products, population health analytics and thought leadership. For more information about Patina, visit https://patinahealth.com.

Additional information:
Other providers are available in the Humana network. Providers may also contract with other Plan Sponsors.

Media Contact

Aimee Eichelberger, Superior PR, 312-952-1528, [email protected]

Kelli LeGaspi, Humana Corporate Communications, (502) 519-5161, [email protected]

SOURCE Patina

NaviMed Capital Promotes Ryan Ross to Managing Director


Bijan Salehizadeh, MD, co-Founder and Managing Director added, “Ryan’s promotion underscores his outstanding leadership and the integral role he has played in NaviMed’s growth over the last several years. Ryan has proven to be a strong partner to NaviMed’s portfolio senior executives. We look forward to his continued success.”

Ryan Ross, Managing Director of NaviMed said, “Since joining the firm, I’ve been fortunate to work with many of NaviMed’s sector-leading portfolio companies and executive teams. NaviMed’s thesis-driven, executive-led strategy has been a blueprint for building and scaling innovative healthcare companies, and I look forward to continuing to implement that strategy in my new role.”

Mr. Ross has over 10 years of private equity investing experience focused on the healthcare industry. He currently serves on the Board of Directors for Advantage Wound & Surgical Care, Citrus Health Group, and Lighthouse Lab Services and is a Board Observer for OPN Healthcare. Mr. Ross has previously served on the board of directors of NaviMed’s investments in CenterPointe Behavioral Health System, CM Group, and Velocity Clinical Research.

Mr. Ross holds a BS in Finance from East Carolina University and an MBA from the Wharton School, University of Pennsylvania.

About NaviMed Capital

NaviMed Capital is a Washington, DC-based private equity firm with over $400 million of assets under management, focused exclusively on the healthcare industry. NaviMed invests in fast growing lower middle-market healthcare businesses that NaviMed believes are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. The firm focuses on healthcare services, healthcare IT, hospital products and pharmaceutical services businesses. NaviMed targets profitable private companies with up to $10 million of EBITDA and double-digit revenue growth. NaviMed’s senior investment team has a track record of value creation spanning, in the aggregate, dozens of investments and more than $11 billion of enterprise value created over the course of their combined careers. For more information, please visit www.navimed.com

Media Contact

Richelle Newman, NaviMed Capital, 1 202-760-2542, [email protected], https://navimed.com/

SOURCE NaviMed Capital

Enhancing R&D Integration with Instrument Connectivity and Data Management, Upcoming Webinar Hosted by Xtalks


Attendees will learn how Benchling takes a platform-based approach to instrument connectivity and standardization of instrument data — plus see a demo of our newly-released platform features and integrations. The featured speakers will cover digital strategies that apply to cell line development, upstream and downstream processing and analytical operations.

Join this webinar to discover how Benchling addresses R&D integration hurdles by focusing on instrument connectivity, data standardization and platform enhancements, revolutionizing scientific processes and analysis lifecycles.

Join experts from Benchling, Jean-Louis Honeine, PhD, Technical Solutions Consultant; and Josi Livingston, Solutions Delivery Manager, for the live webinar on Tuesday, January 23, 2024, at 9am EST (3pm CET/EU-Central).

For more information, or to register for this event, visit Enhancing R&D Integration with Instrument Connectivity and Data Management.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Amorphous Solid Dispersion — An Ideal Formulation Approach to Improve Developability of Poorly Soluble Molecules, Upcoming Webinar Hosted by Xtalks


Solid dispersion refers to the dispersion of one or more active ingredients in a hydrophilic inert carrier matrix at the molecular level. It is prepared by the melt (fusion) method or the solvent evaporation technique. The basic principle of this technique involves the conversion of crystalline drug substance to an amorphous form and stabilised in a hydrophilic polymer.

When the solid dispersion comes in contact with the aqueous medium, the inert carrier dissolves releasing the drug and the increased surface area produces a higher apparent solubility and dissolution rate, thereby increasing the bioavailability of the poorly soluble drug substance.

In this webinar, Sreehari Babu, Sr. Vice President — Formulations Solutions at Aragen Life Sciences, will deep dive into how amorphous solid dispersion is an ideal approach for poorly soluble drug substances and demonstrate how Aragen can offer end-to-end solutions from screening to good manufacturing practice (GMP) supplies through technology overview and case studies.

Join this webinar to learn how amorphous solid dispersion revolutionizes drug solubility, addressing aqueous solubility challenges for enhanced bioavailability and pharmaceutical development.

Join Sreehari Babu Putchakayala, SVP & Head, Formulation Development Solutions, Aragen, for the live webinar on Wednesday, January 24, 2024, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Amorphous Solid Dispersion — An Ideal Formulation Approach to Improve Developability of Poorly Soluble Molecules.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Challenges and Approaches, Upcoming Webinar Hosted by Xtalks


It will also cover the scientific underpinnings of radiomics and AI-based predictive algorithms, grasping the fundamentals, including data preprocessing, algorithm development and practical deployment.

Final discussions center on real-world use cases, demonstrating the tangible impact of these technologies in drug development. From streamlined clinical development and reduced timelines to enhanced success rates and cost reductions, radiomics and AI-based technologies present a large and meaningful value proposition to the drug development and commercialization paradigm. There will also be discussions about the current and future challenges of this field.

Join this webinar to explore the transformative impact of AI and radiomics in drug development, from high-level insights to real-world applications.

Join Ron Korn, MD, PhD, Founder and Chief Medical Officer, Imaging Endpoints; Pamod Hemakumara, Director of Corporate Development, Quibim; and Fuensanta Bellvís Bataller, VP of Clinical Studies, Quibim, for the live webinar on Monday, January 22, 2024, at 2pm EST (11am PST).

For more information, or to register for this event, visit AI and Radiomics in Drug Development: Challenges and Approaches.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Overcoming Challenges in Implementing eConsent in Clinical Trials, Upcoming Webinar Hosted by Xtalks


The featured speaker will cover the following topics:

  •     Navigating regulatory compliance
  •     Bridging the digital divide
  •     Securing eConsent processes
  •     Confirming participant comprehension
  •     Fostering participant engagement

Attendees will also learn practical knowledge to navigate the complex landscape of eConsent implementation, fostering a smoother and more participant-centric informed consent process in clinical trials.

Join this webinar to discover the potential of participant-centered clinical trials through the diverse insights of eConsent, revolutionizing compliance, inclusivity, security, comprehension and engagement strategies.

Join Greg Tullo, Vice President of Professional Services Americas, Viedoc, for the live webinar on Wednesday, January 24, 2024, at 1pm EST (6pm GMT/UK).

For more information, or to register for this event, visit Overcoming Challenges in Implementing eConsent in Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks